Shree Ganesh Biotech India quarterly results and financials

Shree Ganesh Biotech India (BSE 539470)₹0.4600+2.22%(9 Nov 2026 close)Biotechnology

Key facts

In the Jun 2026 quarter (standalone), Shree Ganesh Biotech India reported sales of ₹1.44 Cr, up 3.6% from Jun 2025, and net profit of −₹0.56 Cr, down 275.0% year on year. For the year to Mar 2026, sales were ₹4.96 Cr and net profit ₹0.37 Cr.

Sales (Jun 2026): ₹1.44 Cr
Net profit (Jun 2026): −₹0.56 Cr
Sales (FY Mar 2026): ₹4.96 Cr
Net profit (FY Mar 2026): ₹0.37 Cr
EPS (Jun 2026): ₹0.00
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Shree Ganesh Biotech India quarterly results

₹ crore unless stated; each column is a quarter.

Shree Ganesh Biotech India Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	4.13	4.13	3.79	3.55	1.99	14.42	3.02	1.39	0.78	0.71	2.11	1.44
Expenses	4.05	4.04	4.31	3.70	1.97	13.96	4.44	1.48	1.18	0.76	2.56	2.33
Operating Profit	0.07	0.08	−0.51	−0.12	0.01	0.46	−1.41	−0.08	−0.39	−0.04	−0.42	−0.88
OPM %	2.0%	2.2%	−13.7%	−3.6%	1.0%	3.3%	−47.2%	−6.5%	−51.9%	−7.1%	−20.2%	−62.2%
Other Income	0.00	0.00	1.05	0.36	0.29	0.29	0.46	0.41	0.40	0.36	0.27	0.31
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.07	0.08	0.53	0.23	0.31	0.76	−0.94	0.32	0.00	0.31	−0.14	−0.56
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	0.07	0.08	0.53	0.23	0.31	0.76	−0.94	0.32	0.00	0.31	−0.14	−0.56
EPS (Rs)	0.00	0.00	0.00	0.00	0.00	0.01	−0.01	0.00	0.00	0.00	0.00	0.00

Shree Ganesh Biotech India profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Shree Ganesh Biotech India Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2.13	8.55	7.87	5.88	2.48	17.23	72.65	62.53	20.30	22.99	4.96	5.04
Expenses	1.48	4.79	4.37	4.09	2.24	16.53	69.28	60.46	20.51	24.06	5.95	6.83
Operating Profit	0.64	3.75	3.49	1.78	0.23	0.70	3.44	2.14	−0.19	−1.04	−0.95	−1.73
OPM %	30.7%	44.1%	44.6%	30.6%	9.7%	4.2%	4.8%	3.5%	−1.0%	−4.6%	−19.3%	−34.3%
Other Income	0.03	0.00	0.00	0.00	0.00	−0.27	0.04	0.55	1.05	1.43	1.46	1.34
Interest	0.06	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.54	3.72	3.49	1.78	0.23	0.42	3.49	2.70	0.85	0.38	0.50	−0.39
Tax %	1.8%	0.0%	0.0%	0.0%	0.0%	25.5%	27.7%	25.1%	26.7%	28.2%	27.4%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	−0.22	0.00	0.00	0.00	0.00	0.00	—
Net Profit	0.53	3.72	3.48	1.78	0.23	0.31	2.52	2.03	0.61	0.27	0.37	−0.39
EPS (Rs)	0.14	1.00	0.94	0.03	0.00	0.00	0.05	0.04	0.01	0.00	0.00	0.00
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Shree Ganesh Biotech India balance sheet

₹ crore, at each year end.

Shree Ganesh Biotech India Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	1.83	1.83	1.82	1.82	19.87	19.87	19.88	19.86	39.75	39.76	39.76	39.75
Reserves	2.41	2.94	17.51	20.99	37.22	37.46	37.79	40.30	22.44	23.10	23.35	23.73
Borrowings	0.60	0.49	0.05	0.18	0.18	0.18	0.18	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.12	0.03	0.01	3.28	6.63	7.04	16.58	33.08	17.10	10.58	0.24	0.16
Total Liabilities	4.96	5.29	19.39	26.27	63.90	64.55	74.43	93.24	79.29	73.44	63.35	63.64
Fixed Assets	2.39	2.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.22	0.22	0.00	0.00	0.00	0.00	3.07	3.23	0.00	0.00	9.17	9.16
Other Assets	2.35	2.76	19.39	26.27	63.90	64.55	71.36	90.01	79.29	73.44	54.18	54.48
Inventories	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.88	11.70
Trade receivables	1.21	2.66	9.02	13.56	19.22	20.84	28.42	44.01	19.39	3.31	0.00	0.00
Cash & equivalents	0.18	0.02	0.04	0.04	0.05	0.03	0.03	0.05	0.49	0.44	0.02	0.02
Total Assets	4.96	5.29	19.39	26.27	63.90	64.55	74.43	93.24	79.29	73.44	63.35	63.64

Shree Ganesh Biotech India cash flow

₹ crore, for each year.

Shree Ganesh Biotech India Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.08	−0.05	−12.98	2.24	−0.51	−1.02	2.37	3.58	10.58	10.20	−10.24	−8.22
Cash from investing activity	−0.10	0.00	2.52	−2.35	−32.01	0.98	−2.35	−3.36	−10.07	−10.18	9.77	8.17
Cash from financing activity	0.27	−0.10	10.41	0.12	32.54	0.00	0.00	−0.18	0.00	0.00	0.00	0.00
Net cash flow	0.09	−0.15	0.01	0.00	0.00	−0.01	0.00	0.00	0.43	−0.04	−0.40	0.00
Capex	0.00	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Free cash flow	−0.06	−0.03	−10.58	2.22	−0.50	−1.00	2.35	3.56	10.50	10.12	−10.17	−8.17
CFO / OP %	−14.0%	−6.0%	−344.0%	64.0%	−28.0%	−421.0%	347.9%	132.0%	522.0%	−5,080.0%	972.0%	843.0%

Shree Ganesh Biotech India ratios

Working-capital days and returns, by year.

Shree Ganesh Biotech India Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	261	456	384	628	1,191	3,072	601	221	113	59	0	0
Inventory days	483	0	0	0	0	0	0	0	0	0	47	846
Days payable	46	—	—	—	—	—	—	—	—	—	0	0
Cash conversion cycle	698	456	384	628	1,191	3,072	601	221	113	59	47	846
Working capital days	310	380	383	475	778	2,035	248	53	12	−133	49	860
ROCE %	9.0%	12.2%	30.4%	16.4%	4.4%	0.4%	1.2%	5.9%	4.4%	1.4%	0.6%	0.8%

Shree Ganesh Biotech India: frequently asked questions

What are the latest quarterly results of Shree Ganesh Biotech India?

For the Jun 2026 quarter, Shree Ganesh Biotech India reported sales of ₹1.44 Cr, up 3.6% year on year and net profit of −₹0.56 Cr, down 275.0% year on year. The operating margin was −62.2%.

What is the annual revenue of Shree Ganesh Biotech India?

Shree Ganesh Biotech India's sales for the year to Mar 2026 were ₹4.96 Cr; over the last twelve months they were ₹5.04 Cr.

What is the net profit of Shree Ganesh Biotech India?

Net profit for the year to Mar 2026 was ₹0.37 Cr, and −₹0.39 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.00.

How much debt does Shree Ganesh Biotech India have?

Shree Ganesh Biotech India reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.02 Cr.

What is the free cash flow of Shree Ganesh Biotech India?

Cash from operations was −₹8.22 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹8.17 Cr.

Loading…